Takehiko Nagao Selected Research

Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)

1/2018

High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): A Randomized Superiority Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takehiko Nagao Research Topics

Disease

16	Ischemic Stroke 03/2022 - 11/2007
15	Stroke (Strokes) 03/2022 - 11/2007
11	Atrial Fibrillation 01/2022 - 04/2012
10	Hemorrhage 01/2022 - 06/2008
8	Transient Ischemic Attack 03/2022 - 06/2016
5	Hemorrhagic Stroke 03/2022 - 06/2008
5	Infarction (Infarctions) 01/2022 - 06/2016
4	Cerebral Hemorrhage 03/2022 - 01/2009
4	Embolic Stroke 07/2021 - 06/2016
3	Embolism (Embolus) 04/2021 - 04/2012
3	Myocardial Infarction 01/2019 - 01/2018
2	Hypertension (High Blood Pressure) 03/2022 - 01/2021
2	Hematoma 12/2019 - 01/2009
2	Cerebral Infarction 01/2019 - 06/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 06/2008
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 04/2012 - 07/2010
1	Dyslipidemias (Dyslipidemia) 03/2022
1	Diabetes Mellitus 03/2022
1	Atherosclerosis 02/2021
1	Disease Progression 12/2019
1	Venous Thrombosis (Deep-Vein Thrombosis) 12/2019
1	Cognitive Dysfunction 01/2018
1	Dementia (Dementias) 01/2018
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018
1	Thromboembolism 04/2017
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 07/2010
1	Psychotic Disorders (Schizoaffective Disorder) 04/2007
1	Muscle Rigidity 04/2007
1	Mental Disorders (Mental Disorder) 04/2007
1	Parkinson Disease (Parkinson's Disease) 04/2007
1	Schizophrenia (Dementia Praecox) 04/2007
1	Alzheimer Disease (Alzheimer's Disease) 03/2007

Drug/Important Bio-Agent (IBA)

8	AnticoagulantsIBA 03/2022 - 04/2012
7	Warfarin (Coumadin)FDA LinkGeneric 12/2019 - 06/2008
6	RivaroxabanIBA 01/2022 - 06/2016
5	Vitamin K FDA Link 03/2022 - 04/2012
4	Clopidogrel (Plavix)FDA Link 02/2021 - 04/2018
4	Prasugrel Hydrochloride FDA Link 02/2021 - 04/2018
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2021 - 06/2008
3	Fibrinolytic Agents (Antithrombotic Agents)IBA 07/2010 - 06/2008
2	N(4)-oleylcytosine arabinosideIBA 03/2022 - 09/2015
2	Tissue Plasminogen Activator (Alteplase)FDA Link 03/2022 - 07/2021
2	Dabigatran FDA Link 04/2017 - 04/2012
1	fibrin fragment D (D-dimer)IBA 03/2022
1	Natriuretic PeptidesIBA 03/2022
1	Tenecteplase FDA Link 03/2022
1	Heparin (Liquaemin)FDA LinkGeneric 01/2022
1	Hemoglobins (Hemoglobin)IBA 07/2021
1	ThienopyridinesIBA 01/2021
1	Pharmaceutical PreparationsIBA 12/2019
1	Sulfates (Sulfates, Inorganic)IBA 04/2018
1	LDL CholesterolIBA 01/2018
1	pitavastatin (itavastatin)FDA Link 01/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018
1	oxidized low density lipoproteinIBA 01/2018
1	CoagulantsIBA 08/2017
1	EdaravoneIBA 08/2013
1	argatroban (MPQA)FDA Link 08/2013
1	Factor Xa InhibitorsIBA 04/2012
1	Contrast MediaIBA 11/2007
1	Therapeutic UsesIBA 04/2007
1	Antipsychotic Agents (Antipsychotics)IBA 04/2007

Therapy/Procedure

16	Therapeutics 01/2022 - 11/2007
2	Thrombectomy 03/2022 - 01/2022
1	Drug Therapy (Chemotherapy) 12/2019
1	Secondary Prevention 06/2016
1	Ambulatory Care (Outpatient Care) 07/2010
1	Thrombolytic Therapy 11/2007
1	Gamma Cameras (Gamma Camera) 03/2007